Alyssumtx
1 known investors
Alyssum Therapeutics is a clinical-stage biotech developing small-molecule immunotherapies that modulate B cells to treat solid cancers and other complex diseases. Its lead molecule, AT-1965, inhibits the novel target CMTR2 and recruits a B cell immune response, and the company uses a patented quantum mechanics platform to optimize drug efficacy and safety.
Investors · 1
Frequently asked questions
- What does Alyssumtx do?
- Alyssum Therapeutics is a clinical-stage biotech developing small-molecule immunotherapies that modulate B cells to treat solid cancers and other complex diseases. Its lead molecule, AT-1965, inhibits the novel target CMTR2 and recruits a B cell immune response, and the company uses a patented quantum mechanics platform to optimize drug efficacy and safety.
- Who are Alyssumtx's investors?
- Alyssumtx's investors include FemHealth Ventures.